|  |  |  | Incident fracture |  |  |
---|---|---|---|---|---|---|
 |  |  | No |  | Yes | p-value |
 |  |  | n = 12,303 |  | n = 6023 |  |
 | na |  |  |  |  |  |
Age at menarche | 17,189 |  | n (%) |  | n (%) | < 0.001 |
  < 11 |  | (years) | 826 (7.2) |  | 335 (5.9) |  |
 12–15 |  | (years) | 9731 (84.4) |  | 4774 (84.3) |  |
  > 16 |  | (years) | 968 (8.4) |  | 555 (9.8) |  |
Age at menopause | 12,468 | Â | Â | Â | Â | 0.029 |
  < 40 |  | (years) | 358 (4.5) |  | 172 (3.8) |  |
 40–44 |  | (years) | 776 (9.8) |  | 443 (9.8) |  |
 45–54 |  | (years) | 6085 (76.6) |  | 3438 (76.0) |  |
  > 55 |  | (years) | 723 (9.1) |  | 473 (10.5) |  |
Number of born children | 17,028 | Â | Â | Â | Â | 0.01 |
 no children |  |  | 1466 (12.8) |  | 756 (13.5) |  |
 1–2 children |  |  | 7347 (64.2) |  | 3455 (61.8) |  |
  ≥ 3 children |  |  | 2628 (23.0) |  | 1376 (24.6) |  |
Total duration of lactation | 18,326 | Â | Â | Â | Â | Â |
 no lactation |  | (months) | 3202 (26.0) |  | 1623 (26.9) | 0.002 |
 1–6 |  | (months) | 3918 (31.8) |  | 1752 (29.1) |  |
 7–18 |  | (months) | 4180 (34.0) |  | 2149 (35.7) |  |
  ≥ 19 |  | (months) | 1003 (8.2) |  | 499 (8.3) |  |
Age at first delivery | 14,794 | Â | Â | Â | Â | 0.007 |
  ≤ 19 |  | (years) | 1295 (13.0) |  | 542 (11.2) |  |
 20–34 |  | (years) | 8318 (83.5) |  | 4121 (85.4) |  |
  ≥ 35 |  | (years) | 354 (3.6) |  | 164 (3.4) |  |
Ever use of menopausal hormone therapy | 7441 | (yes) | 1336 (26.4) | Â | 663 (27.8) | 0.229 |
Hysterectomy and/or salpingoophorectomy | 7457 | (yes) | 769 (15.2) | Â | 396 (16.6) | 0.125 |
Miscarriages > 3 | 3892 | (yes) | 249 (9.5) |  | 139 (10.9) | 0.157 |
Ever use of oral contraceptives | 17,306 | (yes) | 6049 (49.2) |  | 2441 (40.5) | < 0.001 |
Total use of oral contraceptives | 8206 | Â | Â | Â | Â | 0.027 |
  < 10 |  | (years) | 3676 (62.8) |  | 1525 (64.9) |  |
 11–19 |  | (years) | 1162 (19.8) |  | 471 (20.1) |  |
  > 20 |  | (years) | 1020 (17.4) |  | 352 (15.0) |  |
 |  |  | median (Q2-Q4b) |  | median (Q2-Q4b) |  |
Start use of oral contraceptives at age | 8323 | (age) | 25.0 (21.0–31.0) |  | 27.0 (22.0–34.0) | < 0.001 |
Reproductive period | 12,398 | (years) | 36.0 (33.0–39.0) |  | 36.0 (33.0–39.0) | 0.088 |
Total use of menopausal hormone therapy | 1763 | (years) | 3.0 (2.0–6.0) |  | 3.0 (2.0–7.8) | 0.004 |